Generate a tailored SOP for Dr. Mark Cragg. Improve your application with a focused, well-structured draft.
Mark Cragg graduated from Bath University in 1994 with a first-class degree in Biochemistry. His educational trajectory includes placements at Glaxo Wellcome and Northeastern University in Boston. He undertook his PhD in Immunology and Immunochemistry at the University of Southampton, where he was awarded a career track fellowship by the School of Medicine. Cragg further enhanced his career with a prestigious fellowship from the Leukaemia Research Fund, which allowed him to study in the world-class laboratory of Andreas Strasser at the Walter Eliza Hall Institute in Melbourne. Upon returning to the UK in 2007, he established his own research group within the Cancer Sciences at the University of Southampton, where he is a member of the Antibody Vaccine Group. His group's research interests focus on antibodies and small molecule inhibitors that understand therapeutics to delete tumor cells augmented with a multi-disciplinary approach connecting academia and industry. Mark has received various accolades, including the University of Southampton Vice-Chancellor's Award for Research Impact in 2017 and the Fellow of the Academy of Medical Sciences in 2024.
University of Southampton • Southampton, England
Leads a research group focusing on antibodies and small molecule inhibitors to treat cancer.